Searched for
SPRYCEL TABLETS
Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...06 Mar, 2025, 10.03 AM IST- Stocks in the news: Voda Idea, NDTV, Lupin, LTTS, Macrotech, and KIMSAdani group and NDTV's promoter entity RRPR Holding have approached Sebi, seeking clarity on the applicability of the regulator's earlier o...30 Aug, 2022, 07.09 AM IST
- Lupin gets USFDA nod for generic cancer treatment drugLupin in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in ...29 Aug, 2022, 05.09 PM IST
- Alembic gets USFDA nod for cancer treatment drugDasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) i...10 Jun, 2022, 12.19 PM IST
- Cheaper version of cancer drug Dasatinib will have to waitDIPP has shot down a health ministry proposal to consider a government-initiated compulsory licence for cancer drug Dasatinib.27 Mar, 2014, 01.17 PM IST
- BDR seeks CL for cancer drug, offers 95% cheaper generic copyThe Mumbai-based firm has applied to the Controller of Patents, Mumbai, seeking the CL for "ease of availability" and "affordability" of th...26 Mar, 2013, 03.59 PM IST
- BDR Pharma seeks cancer drug licenceBDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib19 Mar, 2013, 10.52 AM IST
Load More
